| Product Code: ETC12838350 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Influenza B Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Influenza B Market Revenues & Volume, 2021 & 2031F |
3.3 India Influenza B Market - Industry Life Cycle |
3.4 India Influenza B Market - Porter's Five Forces |
3.5 India Influenza B Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.6 India Influenza B Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 India Influenza B Market Revenues & Volume Share, By Patient Age Group, 2021 & 2031F |
3.8 India Influenza B Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 India Influenza B Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of influenza vaccination in India |
4.2.2 Growing government initiatives to control and prevent influenza outbreaks |
4.2.3 Technological advancements in influenza diagnostics and treatments in the Indian market |
4.3 Market Restraints |
4.3.1 Limited access to healthcare services and vaccines in rural areas of India |
4.3.2 High cost associated with influenza vaccines and treatments for the general population |
4.3.3 Presence of counterfeit or substandard influenza vaccines in the market |
5 India Influenza B Market Trends |
6 India Influenza B Market, By Types |
6.1 India Influenza B Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 India Influenza B Market Revenues & Volume, By Drug Type, 2021 - 2031F |
6.1.3 India Influenza B Market Revenues & Volume, By Antiviral Drugs (Oseltamivir, Zanamivir, Baloxavir), 2021 - 2031F |
6.1.4 India Influenza B Market Revenues & Volume, By Symptom Management (Pain Relievers, Antihistamines), 2021 - 2031F |
6.2 India Influenza B Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 India Influenza B Market Revenues & Volume, By Oral, 2021 - 2031F |
6.2.3 India Influenza B Market Revenues & Volume, By Intravenous, 2021 - 2031F |
6.2.4 India Influenza B Market Revenues & Volume, By Inhalation, 2021 - 2031F |
6.3 India Influenza B Market, By Patient Age Group |
6.3.1 Overview and Analysis |
6.3.2 India Influenza B Market Revenues & Volume, By Pediatric, 2021 - 2031F |
6.3.3 India Influenza B Market Revenues & Volume, By Adult, 2021 - 2031F |
6.3.4 India Influenza B Market Revenues & Volume, By Geriatric, 2021 - 2031F |
6.4 India Influenza B Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 India Influenza B Market Revenues & Volume, By Hospital Pharmacies, 2021 - 2031F |
6.4.3 India Influenza B Market Revenues & Volume, By Retail Pharmacies, 2021 - 2031F |
6.4.4 India Influenza B Market Revenues & Volume, By Online Pharmacies, 2021 - 2031F |
7 India Influenza B Market Import-Export Trade Statistics |
7.1 India Influenza B Market Export to Major Countries |
7.2 India Influenza B Market Imports from Major Countries |
8 India Influenza B Market Key Performance Indicators |
8.1 Percentage increase in influenza vaccination coverage rates in India |
8.2 Number of government-funded influenza prevention programs implemented |
8.3 Adoption rate of advanced influenza diagnostic technologies in healthcare facilities in India |
9 India Influenza B Market - Opportunity Assessment |
9.1 India Influenza B Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.2 India Influenza B Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 India Influenza B Market Opportunity Assessment, By Patient Age Group, 2021 & 2031F |
9.4 India Influenza B Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 India Influenza B Market - Competitive Landscape |
10.1 India Influenza B Market Revenue Share, By Companies, 2024 |
10.2 India Influenza B Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here